- Home
- RLAY vs ECX Comparison
RLAY vs ECX Comparison
Compare RLAY & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- ECX
- Stock Information
- Founded
- RLAY 2015
- ECX 2017
- Country
- RLAY United States
- ECX China
- Employees
- RLAY N/A
- ECX N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- ECX EDP Services
- Sector
- RLAY Health Care
- ECX Technology
- Exchange
- RLAY Nasdaq
- ECX Nasdaq
- Market Cap
- RLAY 803.4M
- ECX 674.7M
- IPO Year
- RLAY 2020
- ECX N/A
- Fundamental
- Price
- RLAY $6.22
- ECX $2.10
- Analyst Decision
- RLAY Strong Buy
- ECX Strong Buy
- Analyst Count
- RLAY 8
- ECX 1
- Target Price
- RLAY $17.25
- ECX $3.20
- AVG Volume (30 Days)
- RLAY 1.7M
- ECX 1.4M
- Earning Date
- RLAY 11-05-2025
- ECX 11-06-2025
- Dividend Yield
- RLAY N/A
- ECX N/A
- EPS Growth
- RLAY N/A
- ECX N/A
- EPS
- RLAY N/A
- ECX N/A
- Revenue
- RLAY $8,355,000.00
- ECX $756,543,682.00
- Revenue This Year
- RLAY $27.33
- ECX $817.95
- Revenue Next Year
- RLAY $7.40
- ECX $29.45
- P/E Ratio
- RLAY N/A
- ECX N/A
- Revenue Growth
- RLAY N/A
- ECX 3.49
- 52 Week Low
- RLAY $1.78
- ECX $0.76
- 52 Week High
- RLAY $7.07
- ECX $3.25
- Technical
- Relative Strength Index (RSI)
- RLAY 71.34
- ECX 52.63
- Support Level
- RLAY $5.47
- ECX $2.04
- Resistance Level
- RLAY $7.00
- ECX $2.37
- Average True Range (ATR)
- RLAY 0.37
- ECX 0.16
- MACD
- RLAY 0.11
- ECX -0.02
- Stochastic Oscillator
- RLAY 70.90
- ECX 42.20
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.